Assignee
EXCELLGENE SA
CH·0 granted patents·5 pending applications·0 citations·filing 2007–2023
Top patents by PatentIndex Score
5 records- 0155US2025368689A1Cross-reactive coronavirus spike protein and methods of use thereofEXCELLGENE SA·Filed 2023·Application pending·0 cites
- 0254US2022112270A1Methods of producing and using recombinant alpha 1-antitrypsin (aat) and compositions thereofEXCELLGENE SA·Filed 2021·Application pending·0 cites
- 0351US2009233334A1Cell cultivation and production of recombinant proteins by means of an orbital shake bioreactor system with disposable bags at the 1,500 liter scaleEXCELLGENE SA·Filed 2008·Application pending·0 cites
- 0447US2009023186A1Use of valproic acid for enhancing production of recombinant proteins in mammalian cellsEXCELLGENE SA·Filed 2007·Application pending·0 cites
- 0546US2010311116A1Fast generation of high expression stable cell lines expressing recombinant proteins under minimal and short-term selective pressureEXCELLGENE SA·Filed 2009·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when EXCELLGENE SA files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →